The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Brain peptides in Alzheimer's disease pathophysiology and therapeutic advances Cell and Tissue Research Springer Nature Link Plasma cadmium is associated with increased risk of long term kidney graft failure Kidney International Protective effects of madecassoside against Doxorubicin induced nephrotoxicity in vivo and in vitro Scientific Reports Anaemia in kidney disease: harnessing hypoxia responses for therapy Nature Reviews Nephrology Anaemia in kidney disease: harnessing hypoxia responses for therapy Nature Reviews Nephrology